Prevention of infections in granulocytopenic patients by fluorinated quinolones.
Rozenberg-Arska
M
M
Department of Clinical Microbiology, University Hospital Utrecht, The Netherlands.
Dekker
A W
AW
Verhoef
J
J
D042462:4-Quinolones; D000380:Agranulocytosis / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D009369:Neoplasms / Q000150:complications*
D042462:4-Quinolones; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents